Welcome to our dedicated page for Accenture Plc Ireland SEC filings (Ticker: ACN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Accenture plc (ACN) SEC filings page brings together the company’s official disclosures to the U.S. Securities and Exchange Commission, including annual and quarterly financial reports, proxy materials and current reports on significant events. As a New York Stock Exchange‑listed company incorporated in Ireland, Accenture uses these filings to provide detailed information on its financial performance, governance, strategy and material developments.
Accenture’s Form 8‑K current reports frequently furnish earnings releases for quarterly and annual periods, outlining revenues, operating margin, earnings per share, bookings, free cash flow and other key metrics. These 8‑K filings also describe the company’s use of non‑GAAP measures such as free cash flow, local‑currency growth and adjusted results that exclude specified business optimization costs, along with reconciliations to GAAP figures. Other 8‑K filings disclose leadership and organizational changes, including updates to Accenture’s growth model and senior management roles.
The company’s definitive proxy statement (DEF 14A) provides extensive detail on corporate governance, board structure, director nominees, executive compensation programs, share incentive plans and shareholder proposals. It also discusses Accenture’s strategy to be the reinvention partner of choice for clients, its Reinvention Services structure, and multi‑year trends in revenue growth, margins, earnings and cash returned to shareholders.
Through this page, users can access Accenture’s 10‑K annual reports, 10‑Q quarterly reports, 8‑K current reports, proxy statements and related exhibits as they are filed with the SEC’s EDGAR system. Stock Titan enhances these documents with AI‑powered summaries that highlight the main points of lengthy filings, explain non‑GAAP reconciliations, and surface items such as compensation plans and governance proposals. Investors tracking ACN can use these filings to review historical performance, understand management’s reporting practices and monitor material events affecting the company.
Accenture plc Chair and CEO Julie Sweet reported a planned sale of Class A ordinary shares under a Rule 10b5-1 trading plan. On February 10, 2026, she sold a total of 6,057 shares in multiple transactions at weighted average prices between $236.11 and $243.1479. Following these sales, she directly owned 15,255 Class A shares.
A holder has filed a notice to sell 6,057 Class A Ordinary shares under Rule 144 through UBS Financial Services, Inc. on the NYSE, with an aggregate market value of
The shares to be sold were acquired as a stock award from the issuer on 02/01/2026. The filer, identified in recent sales as Julie Sweet, has sold additional Class A Ordinary shares in the past three months, including 5,500 shares on 02/03/2026 and 1,694 shares on 01/14/2026.
Accenture plc director Masahiko Uotani reported a transaction involving the company’s Class A ordinary shares. On February 6, 2026, 300 shares were disposed of at $236.545 per share, leaving him with 1,238 Class A ordinary shares held directly after the transaction.
Accenture plc director Arun Sarin reported a small insider share disposition. On 02/06/2026, he disposed of 225 Class A ordinary shares at a price of $236.545 per share. Following this transaction, he directly beneficially owned 9,597 Class A ordinary shares of Accenture.
Accenture plc director Tracey Thomas Travis reported a disposition of 313 Class A ordinary shares of Accenture on February 6, 2026 at a price of $236.545 per share. After this transaction, Travis beneficially owns 9,794 Class A ordinary shares, held directly.
Accenture plc director Jennifer Nason reported a disposition of 224 Class A ordinary shares on February 6, 2026 at a price of $236.545 per share. After this transaction, she beneficially owns 1,314 Class A ordinary shares, all held as direct ownership.
Accenture plc director Martin Brudermueller reported a small share disposition in a Form 4 filing. On 02/06/2026, a transaction coded “F” involved 379 Class A ordinary shares at $236.545 per share. Following this transaction, he directly owned 1,669 Class A ordinary shares.
Accenture plc director Nancy McKinstry reported a small share transaction. On 02/06/2026, she disposed of 398 Class A ordinary shares of Accenture at a price of $236.545 per share, coded as transaction type "F." After this transaction, she directly owned 8,080 Class A ordinary shares.
Accenture plc director Venkata S. M. Renduchintala reported a small share disposition in a Form 4 filing. On 02/06/2026, 224 Class A ordinary shares were disposed of at a price of $236.545 per share using transaction code "F." After this transaction, 4,398 Class A ordinary shares are reported as beneficially owned in direct form.
Accenture director Alan C. Jope reported a Form 4 transaction involving 287 Class A ordinary shares on 02/06/2026 at $236.545 per share. After this transaction, he beneficially owned 3,189 Class A ordinary shares directly.